Exsulin Corporation, a therapeutic development company, develops and commercializes drugs for the treatment of type 1 and type 2 diabetes. Its products include Exsulin, which uses a synthetic version of naturally-occurring peptide that induces regeneration of normal functioning pancreatic islet cells. The company was incorporated in 2006 and is